ReviewJHLT open2026
Pretransplant screening for infections in lung and heart transplant candidates.
Review in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pre-Transplant Infection Screening and Vaccination During Prolonged Waiting Periods for Lung Transplantation in Donor-Limited Asia-Pacific Settings.Respirology (Carlton, Vic.) · 2026Article
- Incidental Detection of Respiratory Viruses in Lung Transplant Donor-Recipient Pairs: Exploratory Associations With Clinical Outcomes in a Post Hoc Analysis.Transplant infectious disease : an official journal of the Transplantation SocietyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solid organ transplantation (SOT) is the definitive treatment for end-stage organ disease but also introduces a heightened risk of infection in the post-transplant period. In heart and lung transplantation, unique factors predisposing to infection include exposure of the lungs to the external environment, alteration of airway anatomy, pretransplant infection and colonization with difficult-to-treat organisms, and pretransplant presence of infected devices. This is in addition to risks common to all SOT leading, including immunosuppression. The aim of pretransplant infectious disease screening in SOT recipients is to prospectively identify infectious risks through careful history taking, examination, and laboratory testing, as well as mitigating these risks through vaccination, treatment, prophylaxis, and counseling on safe living. In this article, we review infectious risks in heart and lung transplant candidates and discuss recommendations for screening before transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.